Treatment of anemia in cancer patients undergoing chemotherapy with intravenous ferric carboxymaltose without erythropoiesis-stimulating agents

BACKGROUND: Anemia is commonly encountered in cancer patients receiving active chemotherapy. Due to adverse events and presumed negative effects on disease-progression and survival, erythropoiesis-stimulating agents are not frequently used. In this study, we assess the efficacy and safety of intrave...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdel-Razeq, Hikmat, Saadeh, Salwa S., Malhis, Razan, Yasser, Sameer, Abdulelah, Hazem, Eljaber, Rana, Kleib, Amer, Ismael, Rouba
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485004/
https://www.ncbi.nlm.nih.gov/pubmed/32952616
http://dx.doi.org/10.1177/1758835920953292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485004/
https://www.ncbi.nlm.nih.gov/pubmed/32952616
http://dx.doi.org/10.1177/1758835920953292

Ejemplares similares